These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6152839)

  • 1. Graves' disease--the thyroid stimulating antibody and immunological networks.
    Farid NR; Briones-Urbina R; Bear JC
    Mol Aspects Med; 1983; 6(5):355-457. PubMed ID: 6152839
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
    Kálmán K; Leövey A; Hauck M; Szabo J; Bako G
    Radiobiol Radiother (Berl); 1987; 28(5):576-9. PubMed ID: 2894705
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of Graves' disease.
    Gossage AA; Munro DS
    Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption of thyroid-stimulating antibody (TSAb) of Graves' disease by homologous and heterologous thyroid tissue.
    Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1978 Oct; 47(4):906-8. PubMed ID: 95627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of hyperthyroidism.
    Chopra IJ; Solomon DH
    Annu Rev Med; 1983; 34():267-81. PubMed ID: 6134495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors.
    Murakami M; Miyashita K; Kakizaki S; Saito S; Yamada M; Iriuchijima T; Takeuchi T; Mori M
    Eur J Endocrinol; 1995 Jul; 133(1):80-6. PubMed ID: 7627342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between thyroid adenylate cyclase-stimulating and thyrotropin-binding inhibitor immunoglobulins in Graves' disease.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1985 May; 84(5):579-85. PubMed ID: 2864384
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
    J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.